Package 52427-273-75

Brand: naprelan

Generic: naproxen sodium
NDC Package

Package Facts

Identity

Package NDC 52427-273-75
Digits Only 5242727375
Product NDC 52427-273
Product ID 52427-273_cc98185d-7e2e-eea6-8bbd-08585361b654
Description

75 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (52427-273-75)

Marketing

Marketing Status
Discontinued 2027-07-01
Brand naprelan
Generic naproxen sodium
Sample Package No

Linked Drug Pages (1)

Naprelan ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "cc98185d-7e2e-eea6-8bbd-08585361b654", "openfda": {"upc": ["0352427272011", "0352427274305", "0352427273759"], "unii": ["9TN87S3A3C"], "rxcui": ["1116320", "1116331", "1116339", "1116341", "1116349", "1116351"], "spl_set_id": ["e633ff0b-eab7-f167-8d08-e9236e54042b"], "manufacturer_name": ["Almatica Pharma LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "75 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (52427-273-75)", "package_ndc": "52427-273-75", "marketing_end_date": "20270701", "marketing_start_date": "20140117"}], "brand_name": "Naprelan", "product_id": "52427-273_cc98185d-7e2e-eea6-8bbd-08585361b654", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "52427-273", "generic_name": "Naproxen Sodium", "labeler_name": "Almatica Pharma LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naprelan", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "500 mg/1"}], "application_number": "NDA020353", "marketing_category": "NDA", "marketing_end_date": "20270701", "marketing_start_date": "20140117"}